The changes of complete blood counts (CBC) during coronavirus 2019 infection and after treatment among non-communicable diseases (NCDs) patients, Map Ta Phut area, Rayong Province
Keywords:
Covid-19, Completed blood cells, NCD patient’s, Map Ta PhutAbstract
The purpose of this descriptive study was to investigate the change in CBC, and comparing CBC between during COVID-19 infection and after treatment among non-communicable diseases (NCDs) patients. The sample was selected by purposive sampling to receive treatment in a hospital and field hospital in the Map Ta Phut area, Rayong Province. The total number of samples was 81 NCD patients. The research instruments were an interview questionnaire and blood sampling. Then the CBC was analyzed, including red blood cells, white blood cells, and platelets. The data collection was repeated twice on the same patient. The first time, a blood sample was collected on the first day of antigen test kit (ATK) that found COVID-19 infection, and admitted to hospital. The collected the second time, on the day that the doctor allowed the patients to go home without ATK for COVID-19 infection. Analyze the data by calculating the percent change and statistically comparing it with the Paired Sample t-test.
The results showed that during the infection, the patient had the most of mean corpuscular hemoglobin concentration (MCHC) abnormality, at 60.5 percent. After treatment, the abnormality was reduced to 40.7%. (change of 48.5 %), followed in descending order by mean corpuscular hemoglobin (MCH) and hemoglobin (Hb) abnormalities of 59.3 and 43.2 %, respectively. For the comparative analysis results, it was found that during COVID-19 infection, patients had a statistically significantly greater increase in mean corpuscular volume (MCV), MCH, white blood cells (WBC), lymphocyte (LY), eosinophil (EO), and platelet (PLT) after treatment (p<0.05). However, on the other hand, during COVID-19 infection, the patients had statistically significantly lower MCHC, RBC distribution width (RDW), monocyte (MO), and neutrophil (NE) than after treatment (p<0.05). These findings suggest that the CBC changes during COVID-19 infection, especially white blood cells, which are the body's natural immune response. Thus, the patients should be monitored for the key of health effects by measuring the white blood cell count.
References
Ali, N. (2021). Relationship between COVID-19 infection and liver injury: A review of recent data. Retrieved from https://doi:10.3389/fmed.2020.00458
Anurag, A., Jha, P. K., & Kumar, A. (2020). Differential white blood cell count in the COVID-19: A cross-sectional study of 148 patients. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 14(6), 2099-2102.
Bunsarai, A., Polyong, P. C., Pairpiroon, S., & Konsombatsuk, M. (2022). Comparison of blood biochemical levels in NCDs patients receiving anti-infective novel coronavirus disease-2019 drugs, Map Ta Phut district, Rayong province. Thai Journal of Health Education, 45(1), 102-113. [in Thai]
Chailak, P., & Sunongbua, A. (2021). The outcome of diabetic patients cares during the prevention of covid-19 pandemic situation at Mueang Chaiyaphum primary care unit, 2020, Chaiyaphum Medicine Journal, 41(1), 111-121. [in Thai]
CSSEGIS and DATA. (2022). COVID-19 data repository by the center for systems science and engineering (CSSE) at Johns Hopkins University. Retrieved from https://github.com/CSSEGISandData/COVID-19
Deeruksa, L., & Sanchaisuriya, K. (2017). Anemia in the elderly in Northeastern Thailand: A community-based study investigating prevalence, contributing factors, and hematologic features. Acta Haematologica, 138(2), 96-102.
Ekburanawat, W. (2017). Interpretation of complete blood count results. Retrieved from https://www.summacheeva.org/article/cbc ([in Thai]
Güçlü, E., Kocayiğit, H., Okan, H. D., Erkorkmaz, U., Yürümez, Y., Yaylacı, S., Koroglu, M., Uzun, C., & Karabay, O. (2020). Effect of COVID-19 on platelet count and its indices. Revista da Associacao Medica Brasileira, 66(8), 1122-1127.
Hansomboon, P. (2021). Medical expenses for COVID-19. Journal of The Department of Medical Services, 46(1), 5-9. [in Thai]
Horton, R. (2021). COVID-19: A new lens for non-communicable diseases. Lancet Glob Health, 8(1), 1003-1017.
Kim, S. R., Nam, S. H., & Kim, Y. R. (2020). Risk factors on the progression to clinical outcomes of COVID-19 patients in South Korea: Using national data. International Journal of Environmental Research and Public Health, 17(23), 1-9. Retrieved from https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7730903/
Mu, T., Yi, Z., Wang, M., Wang, J., Zhang, C., Chen, H., Bai, M., Jiang, L., & Zhang, Y. (2021). Expression of eosinophil in peripheral blood of patients with COVID 19 and its clinical significance. Journal of Clinical Laboratory Analysis, 35(1), 1-6.
Oxford University Hospitals. (2020). Long term respiratory complications of COVID-19. Retrieved from https://www.bmj.com/content/370/bmj.m3001
Ozcelik, N., Ozyurt, S., Kara, B. Y., Gumus, A., & Sahin, U. (2021). The value of the platelet counts and platelet indices in differentiation of COVID-19 and influenza pneumonia. Journal of Medical Virology, 93(4), 2221-2226.
Palmer, K., Monaco, A., Kivipelto, M., Onder, G., Maggi, S., Michel, J. P., Prieto, R., Sykara, G., & Donde, S. (2020). The potential long‑term impact of the COVID‑19 outbreak on patients with non-communicable diseases in Europe: Consequences for healthy ageing. Aging Clinical and Experimental Research, 32(7), 1189-1194.
Patipanwat, P. (2022). Factors of affecting fatality with COVID-19 patients in Kalasin hospital. Journal of Health and Environmental Education, 7(1), 64-71. [in Thai]
Praison, P., Sareeso, P., Aree, P., Satheannoppakao, W., & Poolviwat, P. (2017). Anemia in elderly people in upper-northern Thailand. Thai Journal of Nursing Council, 32(1), 133-145.
Pozdnyakova, O., Connell, N. T., Battinelli, E. M., Connors, J. M., Fell, G., & Kim, A. (2021). Clinical significance of CBC and WBC morphology in the diagnosis and clinical course of COVID-19 infection. American Journal of Clinical Pathology, 155(3), 364-375.
Qin, C., Zhou, L., Hu, Z., Zhang, S., Yang, S., Tao, Y., Xie, C., Ma, K., Shang, K., Wang, W., & Tian, D. S. (2020). Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clinical Infectious Diseases, 71(15), 762-768.
Tantanate, C. (2020). Complete blood count in COVID-19. Retrieved from https://r8way.moph.go.th/r8wayadmin/page/uploads_file/20200519042313_Sysmex%20Educational%20Article%20Complete%20Blood%20Count%20in%20COVID%20.pdf [in Thai]
Thaenkaew, S., & Wongkham, S. (2016). Application of using blood neutrophil to lymphocyte ratio for prognosis. Srinagarind Medical Journal, 31(5), 332-338. [in Thai]
Thomas, T., Stefanoni, D., Dzieciatkowska, M., Issaian, A., Nemkov, T., Hill, R. C., Francis, R. O., Hudson, K. E., Buehler, P. W., Zimring, J. C., Hod, E. A., Hansen, K. C., Spitalnik, S. L., & D'Alessandro, A. (2020). Evidence of structural protein damage and membrane lipid remodeling in red blood cells from COVID-19 patients. Journal of Proteome Research, 19(11), 4455–4469.
Tong, X., Cheng, A., Yuan, X., Zhong, X., Wang, H., Zhou, We., Xu, X., & Li, Y. (2021). Characteristics of peripheral white blood cells in COVID-19 patients revealed by a retrospective cohort study. BMC Infectious Diseases, 21(1), 1236. Retrieved from https://doi.org/10.1186/s12879-021-06899-7
Vickers, A. J. (2001). The use of percentage change from baseline as an outcome in a controlled trial is statistically inefficient: A simulation study. Medical Research Methodology, 1(6), 1-4.
Wang, H. Y., Li, X. L., Yan, Z. R., Sun, X. P., Han, J., & Zhang, B. W. (2020a). Potential neurological symptoms of COVID-19. Therapeutic Advances in Neurological Disorders. Retrieved from https://doi.org/10.1177/1756286420917830
Wang, J., Li, Q., Yin, Y., Zhang, Y., Cao, Y., Lin, X., Huang, L., Hoffmann, D., Lu, M., & Qiu, Y. (2020b). Excessive neutrophils and neutrophil extracellular traps in COVID-19. Frontiers in Immunology. Retrieved from https://doi.org/10.3389/fimmu.2020.02063
World Health Organization [WHO]. (2020). WHO director-general’s opening remarks at the median briefing on COVID-19 – 11 March 2020. Retrieved from https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
